Xenon Pharmaceuticals Announces Q2 2025 Earnings Call Details

Author: Ryan Hughes Updated: 08-04-2025 08:33 AM

Upcoming Q2 2025 Financial Results Announcement

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a leading biopharmaceutical company specialized in neuroscience, has exciting news for investors and partners. The company will be reporting its second quarter financial results for 2025 and providing a business update shortly after the close of U.S. markets. This event is set for Monday, August 11, 2025. It's an excellent opportunity for stakeholders to gain insights into the company's progress and future direction.

Conference Call and Webcast Information

Xenon Pharmaceuticals will host a conference call and webcast to discuss the earnings results. Here are the key details for participants:

Date and Time

The call will take place on Monday, August 11, 2025, at 4:30 PM Eastern Time (1:30 PM Pacific Time). Attendees can sit in for an insightful discussion about the company’s performance and strategic initiatives.

Accessing the Webcast

To join the live stream of the earnings call, participants can pre-register on the designated webcast platform. This session will be recorded and available for replay shortly after the conclusion of the event.

Dial-In Details

For those who prefer to join via phone, a dial-in option will be available. Participants can call (800) 715-9871 toll-free or (646) 307-1963 for international access. Make sure you have the conference ID, 4102397, ready for a smoother experience.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. is committed to developing innovative therapies to elevate the lives of individuals with various neurological disorders. The company is focused on advancing its ion channel product portfolio, aiming to address unmet medical needs, particularly in epilepsy and depression. One of their most promising developments is Azetukalner, a selective Kv7 potassium channel opener, which has shown great potential in late-stage clinical development.

Investor Relations Contact Information

For any inquiries or more information, investors can reach out to Chad Fugere, Vice President of Investor Relations, at (857) 675-7275 or via email at investors@xenon-pharma.com.

Media Inquiries

For media-related questions, please contact Colleen Alabiso, Senior Vice President of Corporate Affairs, at (617) 671-9238 or email at media@xenon-pharma.com.

Frequently Asked Questions

What is the date for Xenon's Q2 2025 financial results?

The Q2 2025 financial results will be reported on August 11, 2025.

How can I access the webcast for the earnings call?

Participants can pre-register for the webcast through the company's official platform.

Who can I contact for investor-related queries?

Chad Fugere, VP of Investor Relations, can be contacted for queries.

What is Azetukalner?

Azetukalner is a selective Kv7 potassium channel opener being developed for neurological conditions.

What is the conference ID for the earnings call?

The conference ID for the earnings call is 4102397.

About The Author

Hello, my name is Ryan Hughes. I am a financial, economics, and stock market specialist committed to assisting people in negotiating the intricacies of the financial system. Having a great deal of experience and a thorough grasp of market dynamics and economic trends, my area of expertise is converting complex financial ideas into understandable, practical knowledge. By use of my articles and blog entries, I hope to give you the information and assurance you need to make wise financial choices.

I've had the honor of interacting with a wide range of readers as a writer for several financial blogs, from new investors to seasoned market participants. To enable you to reach your financial goals, I want to make finance, economics, and stock market trends understandable and approachable. I appreciate you traveling with me toward success and financial literacy.

Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.